6.
Belibasakis G, Guggenheim B, Bostanci N
. Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: involvement of Porphyromonas gingivalis. Innate Immun. 2012; 19(1):3-9.
DOI: 10.1177/1753425912444767.
View
7.
da Motta R, Tirapelli C, Silva R, Villafuerte K, Almeida L, Ribeiro-Silva A
. Immature, but Not Mature, Dendritic Cells Are More Often Present in Aggressive Periodontitis Than Chronic Periodontitis: An Immunohistochemical Study. J Periodontol. 2016; 87(12):1499-1507.
DOI: 10.1902/jop.2016.150729.
View
8.
Koca-Unsal R, Ozer Sehirli A, Sayiner S, Aksoy U
. Relationship of NLRP3 inflammasome with periodontal, endodontic and related systemic diseases. Mol Biol Rep. 2022; 49(11):11123-11132.
DOI: 10.1007/s11033-022-07894-0.
View
9.
Yu L, Zhou C, Wei Z, Shi Z
. Effect of combined periodontal-orthodontic treatment on NOD-like receptor protein 3 and high mobility group box-1 expressions in patients with periodontitis and its clinical significance. Medicine (Baltimore). 2019; 98(44):e17724.
PMC: 6946199.
DOI: 10.1097/MD.0000000000017724.
View
10.
Isola G
. Saliva biotechnology as a diagnostic tool for periodontal diseases: new challenges for clinical practice. Front Biosci (Elite Ed). 2022; 14(2):9.
DOI: 10.31083/j.fbe1402009.
View
11.
Mitra D, Chavan R, Prithyani S, Kandawalla S, Shah R, Rodrigues S
. Comparative evaluation of the levels of nod-like receptor family pyrin domain-containing protein (NLRP) 3 in saliva of subjects with chronic periodontitis and healthy controls. J Indian Soc Periodontol. 2022; 26(3):230-235.
PMC: 9118941.
DOI: 10.4103/jisp.jisp_5_21.
View
12.
Belibasakis G, Johansson A
. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine. 2012; 59(1):124-30.
DOI: 10.1016/j.cyto.2012.03.016.
View
13.
Iwasaki A, Medzhitov R
. Regulation of adaptive immunity by the innate immune system. Science. 2010; 327(5963):291-5.
PMC: 3645875.
DOI: 10.1126/science.1183021.
View
14.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C
. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71.
PMC: 8005924.
DOI: 10.1136/bmj.n71.
View
15.
Martinon F, Mayor A, Tschopp J
. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009; 27:229-65.
DOI: 10.1146/annurev.immunol.021908.132715.
View
16.
Hajishengallis G, Lamont R
. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012; 27(6):409-19.
PMC: 3653317.
DOI: 10.1111/j.2041-1014.2012.00663.x.
View
17.
Shahbeik S, Taleghani F, Sattari M, Mahvash Mohammadi M, Moravej M
. Evaluation of NLRP3 and IL-18 Levels after Periodontal Therapy. Iran J Allergy Asthma Immunol. 2021; 20(6):764-770.
DOI: 10.18502/ijaai.v20i6.8028.
View
18.
Carta S, Penco F, Lavieri R, Martini A, Dinarello C, Gattorno M
. Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance. Proc Natl Acad Sci U S A. 2015; 112(9):2835-40.
PMC: 4352822.
DOI: 10.1073/pnas.1424741112.
View
19.
Boroumand M, Olianas A, Cabras T, Manconi B, Fanni D, Faa G
. Saliva, a bodily fluid with recognized and potential diagnostic applications. J Sep Sci. 2021; 44(19):3677-3690.
PMC: 9290823.
DOI: 10.1002/jssc.202100384.
View
20.
Isola G, Polizzi A, Santonocito S, Alibrandi A, Williams R
. Periodontitis activates the NLRP3 inflammasome in serum and saliva. J Periodontol. 2021; 93(1):135-145.
DOI: 10.1002/JPER.21-0049.
View